We identified 25D3 status as a novel host factor that influences the growth of EGFR mutant lung cancer and discovered that 25D3 signaling persists despite dramatic reduction in CYP27B1 expression and 1αOHase activity. The gene discussed is EGFR; the disease is lung cancer.